62.有關lipid-lowering drugs的機轉和對於血脂的主要影響,下列配對何者最適合?
-
(A)alirocumab PCSK9 inhibitor,降低TG
(B)rosuvastatin-HMG-CoA reductase inhibitor,降低LDL-C
(C)ezetimibe-NPC1L1 inhibitor,提高HDL-C
(D)lomitapide-microsomal TG transfer protein (MTP) inhibitor,降低TG
答案:登入後查看
統計: A(56), B(2341), C(60), D(72), E(0) #3133829
統計: A(56), B(2341), C(60), D(72), E(0) #3133829
詳解 (共 9 筆)
#6016304
(A) alirocumab PCSK9 inhibitor,降低LDL
(B) rosuvastatin-HMG-CoA reductase inhibitor,降低LDL-C
(C) ezetimibe-NPC1L1 inhibitor,降低LDL
(D) lomitapide-microsomal TG transfer protein (MTP) inhibitor,
降低同合子家族性高膽固醇血症引起的低密度膽固醇(LDL-C)
1
1